Design and molecular dynamic simulation of a new double-epitope tolerogenic protein as a potential vaccine for multiple sclerosis disease
One of the debilitating diseases affecting the central nervous system is multiple sclerosis (MS). As there is no definitive treatment for MS, researchers have mainly consented with optimization of strategies which slows down the progression of the disease such as specific auto-antigens tolerance ind...
Main Authors: | Fatemeh Banisharif-Dehkordi, Mohsen Mobini-Dehkordi, Mostafa Shakhsi-Niaei, Karim Mahnam |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Research in Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://www.rpsjournal.net/article.asp?issn=1735-5362;year=2019;volume=14;issue=1;spage=20;epage=26;aulast=Banisharif-Dehkordi |
Similar Items
-
Computational comparison of two new fusion proteins for multiple sclerosis
by: Nasrin Payab, et al.
Published: (2018-01-01) -
Exploiting PLGA-Based Biocompatible Nanoparticles for Next-Generation Tolerogenic Vaccines against Autoimmune Disease
by: Giuseppe Cappellano, et al.
Published: (2019-01-01) -
A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4+ CD25high FOXP3+ Regulatory T Cells in Myelin-Specific TCR Transgenic Mice Contingent Upon Low-Efficiency T Cell Antigen Receptor Recognition
by: Cody D. Moorman, et al.
Published: (2019-01-01) -
MAP7 and MUCL1 Are Biomarkers of Vitamin D3-Induced Tolerogenic Dendritic Cells in Multiple Sclerosis Patients
by: Juan Navarro-Barriuso, et al.
Published: (2019-06-01) -
Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials
by: Georgina Flórez-Grau, et al.
Published: (2018-05-01)